OVID Ovid Therapeutics Inc

Ovid Therapeutics Inc is a US-based biopharmaceutical company. The firm is engaged primarily in developing medicines for patients suffering with rare neurological disorders.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/05/2017
Outstanding shares:  68,092,185
Average volume:  193,446
Market cap:   $226,066,054
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    690469101
ISIN:        US6904691010
Sedol:      BYPFK63
Valuation   (See tab for details)
PE ratio:   1.75
PB ratio:   1.13
PS ratio:   0.53
Return on equity:   64.36%
Net income %:   30.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy